I have created other katas. Have a look if you like coding and challenges.
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study Outcomes for patients ...
Materials Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, California 94720, ...
Note: Some of the code here is old and was written when I was learning C++. It might be possible that code is not safe or making wrong assumptions. Please use with caution. Pull requests are always ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results